Eli Lilly Zepbound Claims

News

Zepbound beats Wegovy for weight loss

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.

· 3d · on MSN

Pasadena Star-News · 3d

Zepbound trims more belly fat than Wegovy, study shows

The Times of Northwest Indiana · 3d

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

22don MSN

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro. Lilly ...

2 Minute Medicine7h

Eli Lilly Takes Legal Action Against Telehealth Startups

Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain in high demand ...

14d

CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.

The Associated Press on MSN14d

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results